Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia

Journal of Neurogenetics

Volumn 28, Issue 1-2, 2014, Pages 70-85

  Pietersen, Charmaine Y ^a,b   Mauney, Sarah A ^a   Kim, Susie S ^a   Passeri, Eleonora ^a,b   Lim, Maribel P ^a   Rooney, Robert J ^c   Goldstein, Jill M ^d   Petreyshen, Tracey L ^e   Seidman, Larry J ^f   Shenton, Martha E ^d   McCarley, Robert W ^b,f,g   Sonntag, Kai C ^a,b   Woo, Tsung Ung W ^a,b,f  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Genome Explorations Inc   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cerebral cortex; Gene expression profiling; Laser capture microdissection; MicroRNA

Indexed keywords

ACYL COENZYME A DESATURASE 1; ADP RIBOSYLATION FACTOR LIKE 5A; CALBINDIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CLOZAPINE; CSRP2 BINDING PROTEIN; DIHYDROPTERIDINE REDUCTASE; DUAL SPECIFICITY PHOSPHATASE 4; DUAL SPECIFICITY PHOSPHATASE 6; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOSYLTRANSFERASE 25 DOMAIN CONTAINING 2; HISTONE H2AY; KAZRIN; LIM HOMEOBOX 6; MEMBRANE PROTEIN 41B; MESSENGER RNA; METHIONINE SULFOXIDE REDUCTASE B2; MICRORNA; NOTCH RECEPTOR; OLANZAPINE; PARVALBUMIN; PERPHENAZINE; PROSTAGLANDIN E2; PROTEIN; RING FINGER PROTEIN 175; RNA; SPERMATID PERINUCLEAR RNA BINDING PROTEIN; TIOTIXENE; UNCLASSIFIED DRUG; WD REPEAT DOMAIN 8; WNT PROTEIN; NOTCH1 PROTEIN, HUMAN; NOTCH1 RECEPTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LASER CAPTURE MICRODISSECTION; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SUPERIOR TEMPORAL GYRUS; UPREGULATION; GENETICS; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; TEMPORAL LOBE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CALBINDINS; DINOPROSTONE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEURONS; PARVALBUMINS; RECEPTOR, NOTCH1; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TEMPORAL LOBE; WNT PROTEINS; YOUNG ADULT;

EID: 84901403714     PISSN: 01677063     EISSN: 15635260     Source Type: Journal    
DOI: 10.3109/01677063.2013.878339     Document Type: Article

References (106)

1. Ables, J. L., Breunig, J. J., Eisch, A. J., & Rakic, P. (2011). Not(ch) just development: Notch signalling in the adult brain. Nat Rev Neurosci, 12, 269-283.
2. Ahmad-Annuar, A., Ciani, L., Simeonidis, I., Herreros, J., Fredj, N. B., Rosso, S. B., et al. (2006). Signaling across the synapse: A role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release. J Cell Biol, 174, 127-139. (Pubitemid 43992902)
3. Anderson, M. F., Aberg, M. A., Nilsson, M., & Eriksson, P. S. (2002). Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res, 134, 115-122. (Pubitemid 34310242)
4. Behrens, M. M., & Sejnowski, T. J. (2009). Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology, 57, 193-200.
5. Benes, F. M. (2011). Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology, 60, 1232-1242.
6. Benes, F. M., & Berretta, S. (2001). GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology, 25, 1-27. (Pubitemid 32493819)
7. Benes, F. M., Kwok, E. W., Vincent, S. L., & Todtenkopf, M. S. (1998). A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry, 44, 88-97. (Pubitemid 28305527)
8. Benes, F. M., Lim, B., Matzilevich, D., Subburaju, S., & Walsh, J. P. (2008). Circuitry-based gene expression profi les in GABA cells of the trisynaptic pathway in schizophrenics versus bipolars. Proc Natl Acad Sci USA, 105, 20935-20940.
9. Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007). Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA, 104, 10164-10169. (Pubitemid 47175280)
10. Benes, F. M., McSparren, J., Bird, E. D., SanGiovanni, J. P., & Vincent, S. L. (1991). Defi cits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry, 48, 996-1001.
11. Beveridge, N. J., Tooney, P. A., Carroll, A. P., Gardiner, E., Bowden, N., Scott, R. J., et al. (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Hum Mol Genet, 17, 1156-1168. (Pubitemid 351494187)
12. Bitanihirwe, B. K., & Woo, T.-U. W. (2011). Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev, 35, 878-893.
13. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., et al. (2011). Modelling schizophrenia using human induced pluripotent stem cells. Nature, 473, 221-225.
14. Budnik, V., & Salinas, P. C. (2011). Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol, 21, 151-159.
15. Cabungcal, J. H., Nicolas, D., Kraftsik, R., Cuenod, M., Do, K. Q., & Hornung, J. P. (2006). Glutathione defi cit during development induces anomalies in the rat anterior cingulate GABAergic neurons: Relevance to schizophrenia. Neurobiol Dis, 22, 624-637. (Pubitemid 43832133)
16. Cabungcal, J. H., Steullet, P., Kraftsik, R., Cuenod, M., & Do, K. Q. (2013a). Early-life insults impair parvalbumin interneurons via oxidative stress: Reversal by N-acetylcysteine. Biol Psychiatry, 73, 574-582.
17. Cabungcal, J. H., Steullet, P., Morishita, H., Kraftsik, R., Cuenod, M., Hensch, T. K., et al. (2013b). Perineuronal nets protect fast-spiking interneurons against oxidative stress. Proc Natl Acad Sci USA, 110, 9130-9135.
18. Caricasole, A., Copani, A., Caruso, A., Caraci, F., Iacovelli, L., Sortino, M. A., et al. (2003). The Wnt pathway, cell-cycle activation and beta-amyloid: Novel therapeutic strategies in Alzheimer's disease? Trends Pharmacol Sci, 24, 233-238. (Pubitemid 36588871)
19. Carlson, M. E., Silva, H. S., & Conboy, I. M. (2008). Aging of signal transduction pathways, and pathology. Exp Cell Res, 314, 1951-1961. (Pubitemid 351649367)
20. Carro, E., Trejo, J. L., Nunez, A., & Torres-Aleman, I. (2003). Brain repair and neuroprotection by serum insulin-"like growth factor I. Mol Neurobiol, 27, 153-162. (Pubitemid 36724518)
21. Chen, J., Park, C. S., & Tang, S. J. (2006). Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem, 281, 11910-11916. (Pubitemid 43855453)
22. Chen, S., Guttridge, D. C., You, Z., Zhang, Z., Fribley, A., Mayo, M. W., et al. (2001). Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol, 152, 87-96. (Pubitemid 32102439)
23. Chun, K. S., & Langenbach, R. (2011). The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol Carcinog, 50, 439-448.
24. Ciani, L., Boyle, K. A., Dickins, E., Sahores, M., Anane, D., Lopes, D. M., et al. (2011). Wnt7a signaling promotes dendritic spine growth and synaptic strength through Ca(2) (-)/Calmodulin-dependent protein kinase II. Proc Natl Acad Sci U S A, 108, 10732-10737.
25. Conboy, L., Seymour, C. M., Monopoli, M. P., O'Sullivan, N. C., Murphy, K. J., & Regan, C. M. (2007). Notch signalling becomes transiently attenuated during long-term memory consolidation in adult Wistar rats. Neurobiol Learn Mem, 88, 342-351. (Pubitemid 47321214)
26. Copani, A., Uberti, D., Sortino, M. A., Bruno, V., Nicoletti, F., & Memo, M. (2001). Activation of cell-cycle-associated proteins in neuronal death: A mandatory or dispensable path? Trends Neurosci, 24, 25-31. (Pubitemid 32332893)
27. Cuitino, L., Godoy, J. A., Farias, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. J Neurosci, 30, 8411-8420.
28. Curley, A. A., Arion, D., Volk, D. W., Asafu-Adjei, J. K., Sampson, A. R., Fish, K. N., et al. (2011). Cortical defi cits of glutamic acid decarboxylase 67 expression in schizophrenia: Clinical, protein, and cell type-specifi c features. Am J Psychiatry, 168, 921-929.
29. Curley, A. A., & Lewis, D. A. (2012). Cortical basket cell dysfunction in schizophrenia. J Physiol, 590 (Pt 4), 715-724.
30. Danesin, C., & Houart, C. (2012). A Fox stops the Wnt: Implications for forebrain development and diseases. Curr Opin Genet Dev, 22, 323-330.
31. Das, A. V., Bhattacharya, S., Zhao, X., Hegde, G., Mallya, K., Eudy, J. D., et al. (2008). The canonical Wnt pathway regulates retinal stem cells/progenitors in concert with Notch signaling. Dev Neurosci, 30, 389-409.
32. Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009). Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol, 19, 220-230.
33. Fan, Y., Abrahamsen, G., McGrath, J. J., & Mackay-Sim, A. (2012). Altered cell cycle dynamics in schizophrenia. Biol Psychiatry, 71, 129-135.
34. Freese, J. L., Pino, D., & Pleasure, S. J. (2010). Wnt signaling in development and disease. Neurobiol Dis, 38, 148-153.
35. Glausier, J. R., & Lewis, D. A. (2011). Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology, 36, 2103-2110.
36. Gogolla, N., Galimberti, I., Deguchi, Y., & Caroni, P. (2009). Wnt signaling mediates experience-related regulation of synapse numbers and mossy fi ber connectivities in the adult hippocampus. Neuron, 62, 510-525.
37. Gonzalez-Burgos, G., Hashimoto, T., & Lewis, D. A. (2010). Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep, 12, 335-344.
38. Guo, D., Ye, J., Dai, J., Li, L., Chen, F., Ma, D., et al. (2009). Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res, 33, 678-685.
39. Hall, A. C., Lucas, F. R., & Salinas, P. C. (2000). Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell, 100, 525-535.
40. Han, C., & Wu, T. (2005). Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem, 280, 24053-24063. (Pubitemid 40884893)
41. Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., et al. (2003). Gene expression defi cits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci, 23, 6315-6326. (Pubitemid 36875633)
42. Hayward, P., Brennan, K., Sanders, P., Balayo, T., DasGupta, R., Perrimon, N., et al. (2005). Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development, 132, 1819-1830. (Pubitemid 40691772)
43. Homayoun, H., & Moghaddam, B. (2007). NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci, 27, 11496-11500. (Pubitemid 350006886)
44. Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci, 11, 77-86.
45. Ishitani, T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003). Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling. Mol Cell Biol, 23, 1379-1389. (Pubitemid 36177046)
46. Jensen, M., Brockie, P. J., & Maricq, A. V. (2012a). Wnt signaling regulates experience-dependent synaptic plasticity in the adult nervous system. Cell Cycle, 11, 2585-2586.
47. Jensen, M., Hoerndli, F. J., Brockie, P. J., Wang, R., Johnson, E., Maxfi eld, D., et al. (2012b). Wnt signaling regulates acetylcholine receptor translocation and synaptic plasticity in the adult nervous system. Cell, 149, 173-187.
48. Kaiya, H., Uematsu, M., Ofuji, M., Nishida, A., Takeuchi, K., Nozaki, M., et al. (1989). Elevated plasma prostaglandin E2 levels in schizophrenia. J Neural Transm, 77, 39-46. (Pubitemid 19140271)
49. Kanehisa, M., & Goto, S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28, 27-30. (Pubitemid 30047706)
50. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res, 38 (Database issue), D355-D360.
51. Kanehisa, M., Goto, S., Hattori, M., Aoki-Kinoshita, K. F., Itoh, M., Kawashima, S., et al. (2006). From genomics to chemical genomics: New developments in KEGG. Nucleic Acids Res, 34 (Database issue), D354-D357.
52. Katsel, P., Davis, K. L., Li, C., Tan, W., Greenstein, E., Kleiner Hoffman, L. B., et al. (2008). Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes. Neuropsychopharmacology, 33, 2993-3009.
53. Kaur, J., & Sanyal, S. N. (2010). PI3-kinase/Wnt association mediates COX-2/PGE(2) pathway to inhibit apoptosis in early stages of colon carcinogenesis: Chemoprevention by diclofenac. Tumour Biol, 31, 623-631.
54. Kinney, J. W., Davis, C. N., Tabarean, I., Conti, B., Bartfai, T., & Behrens, M. M. (2006). A specifi c role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci, 26, 1604-1615. (Pubitemid 43237031)
55. Kulak, A., Steullet, P., Cabungcal, J. H., Werge, T., Ingason, A., Cuenod, M., et al. (2013). Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: Insights from animal models. Antioxid Redox Signal, 18, 1428-1443.
56. Letamendia, A., Labbe, E., & Attisano, L. (2001). Transcriptional regulation by Smads: Crosstalk between the TGF-beta and Wnt pathways. J Bone Joint Surg Am, 83-A Suppl 1 (Pt 1), S31-S39.
57. Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2011). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci, 35, 57-67.
58. Lewis, D. A., Curley, A. A., Glausier, J. R., & Volk, D. W. (2012). Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci, 35, 57-67.
59. Lewis, D. A., Hashimoto, T., & Morris, H. M. (2008). Cell and receptor type-specifi c alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res, 14, 237-248.
60. Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005). Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci, 6, 312-324. (Pubitemid 40469985)
61. Ling, H., Sylvestre, J. R., & Jolicoeur, P. (2010). Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene, 29, 4543-4554.
62. Liodis, P., Denaxa, M., Grigoriou, M., Akufo-Addo, C., Yanagawa, Y., & Pachnis, V. (2007). Lhx6 activity is required for the normal migration and specifi cation of cortical interneuron subtypes. J Neurosci, 27, 3078-3089. (Pubitemid 46474122)
63. Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., et al. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci, 31, 234-242.
64. Liu, D. X., & Greene, L. A. (2001). Neuronal apoptosis at the G1/S cell cycle checkpoint. Cell Tissue Res, 305, 217-228. (Pubitemid 32681898)
65. Luzzi, V., Holtschlag, V., & Watson, M. A. (2001). Expression profi ling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol, 158, 2005-2010. (Pubitemid 32545186)
66. Mahadevappa, M., & Warrington, J. A. (1999). A high-density probe array sample preparation method using 10-to 100-fold fewer cells. Nat Biotechnol, 17, 1134-1136. (Pubitemid 29533558)
67. Malaterre, J., Ramsay, R. G., & Mantamadiotis, T. (2007). Wnt-Frizzled signalling and the many paths to neural development and adult brain homeostasis. Front Biosci, 12, 492-506. (Pubitemid 46852801)
68. Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004). Interneurons of the neocortical inhibitory system. Nat Rev Neurosci, 5, 793-807. (Pubitemid 39336216)
69. Martinez-Gras, I., Perez-Nievas, B. G., Garcia-Bueno, B., Madrigal, J. L., Andres-Esteban, E., Rodriguez-Jimenez, R., et al. (2011). The anti-infl ammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res, 128, 15-22.
70. Mason, H. A., Rakowiecki, S. M., Raftopoulou, M., Nery, S., Huang, Y., Gridley, T., et al. (2005). Notch signaling coordinates the patterning of striatal compartments. Development, 132, 4247-4258. (Pubitemid 41576687)
71. Miele, L., & Osborne, B. (1999). Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol, 181, 393-409. (Pubitemid 29513408)
72. Miller, B. H., Zeier, Z., Xi, L., Lanz, T. A., Deng, S., Strathmann, J., et al. (2012). MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A, 109, 3125-3130.
73. Miron, M., Woody, O. Z., Marcil, A., Murie, C., Sladek, R., & Nadon, R. (2006). A methodology for global validation of microarray experiments. BMC Bioinformatics, 7, 333.
74. Moreau, M. P., Bruse, S. E., David-Rus, R., Buyske, S., & Brzustowicz, L. M. (2011). Altered microRNA expression profi les in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry, 69, 188-193.
75. Muller, N. (2010). COX-2 inhibitors as antidepressants and antipsychotics: Clinical evidence. Curr Opin Investig Drugs, 11, 31-42.
76. Nakazawa, K., Zsiros, V., Jiang, Z., Nakao, K., Kolata, S., Zhang, S., et al. (2011). GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology, 62, 1574-1583.
77. Neves, G., Shah, M. M., Liodis, P., Achimastou, A., Denaxa, M., Roalfe, G., et al. (2012). The LIM homeodomain protein Lhx6 regulates maturation of interneurons and network excitability in the mammalian cortex. Cereb Cortex. 23, 1811-1823.
78. Niehrs, C., & Acebron, S. P. (2012). Mitotic and mitogenic Wnt signalling. EMBO J, 31, 2705-2713.
79. Oishi, K., Kamakura, S., Isazawa, Y., Yoshimatsu, T., Kuida, K., Nakafuku, M., et al. (2004). Notch promotes survival of neural precursor cells via mechanisms distinct from those regulating neurogenesis. Dev Biol, 276, 172-184. (Pubitemid 39452853)
80. Park, D. S., Morris, E. J., Greene, L. A., & Geller, H. M. (1997). G1/S cell cycle blockers and inhibitors of cyclindependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci, 17, 1256-1270. (Pubitemid 27073728)
81. Park, M., & Shen, K. (2012). WNTs in synapse formation and neuronal circuitry. EMBO J, 31, 2697-2704.
82. Pierri, J. N., Chaudry, A. S., Woo, T. U., & Lewis, D. A. (1999). Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry, 156, 1709-1719. (Pubitemid 29517562)
83. Pietersen, C. Y., Lim, M. P., Macey, L., Woo, T.-U. W., & Sonntag, K. C. (2011). Neuronal type-specifi c gene expression profi ling and laser-capture microdissection. Methods Mol Biol, 755, 327-343.
84. Pietersen, C. Y., Lim, M. P., & Woo, T.-U. W. (2009). Obtaining high quality RNA from single cell populations in human postmortem brain tissue. J Vis Exp, 30.
85. Powell, S. B., Sejnowski, T. J., & Behrens, M. M. (2011). Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology, 62, 1322-1331.
86. Rodriguez, D. A., Tapia, J. C., Fernandez, J. G., Torres, V. A., Munoz, N., Galleguillos, D., et al. (2009). Caveolin-1-mediated suppression of cyclooxygenase-2 via a betacatenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell, 20, 2297-2310.
87. Sahores, M., & Salinas, P. C. (2011). Activity-mediated synapse formation a role for Wnt-Fz signaling. Curr Top Dev Biol, 97, 119-136.
88. Santarelli, D. M., Beveridge, N. J., Tooney, P. A., & Cairns, M. J. (2011). Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia. Biol Psychiatry, 69, 180-187.
89. Selemon, L. D., & Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol Psychiatry, 45, 17-25. (Pubitemid 29049200)
90. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A, 96, 5522-5527. (Pubitemid 29234650)
91. Simunovic, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., et al. (2009). Gene expression profi ling of substantia nigra dopamine neurons: Further insights into Parkinson's disease pathology. Brain, 132 (Pt 7), 1795-1809.
92. Singer, W., Gray, C., Engel, A., Konig, P., Artola, A., & Brocher, S. (1990). Formation of cortical cell assemblies. Cold Spring Harb Symp Quant Biol, 55, 939-952.
93. Soltesz, I. (2005). Diversity in the neuronal machine. New York: Oxford University Press.
94. Spencer, K. M. (2009). The functional consequences of cortical circuit abnormalities on gamma oscillations in schizophrenia: Insights from computational modeling. Front Hum Neurosci, 3, 33.
95. Spencer, K. M., Nestor, P. G., Perlmutter, R., Niznikiewicz, M. A., Klump, M. C., Frumin, M., et al. (2004). Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A, 101, 17288-17293. (Pubitemid 39627812)
96. Steullet, P., Neijt, H. C., Cuenod, M., & Do, K. Q. (2006). Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione defi cit: Relevance to schizophrenia. Neuroscience, 137, 807-819. (Pubitemid 43053945)
97. Tiberi, L., Vanderhaeghen, P., & van den Ameele, J. (2012). Cortical neurogenesis and morphogens: Diversity of cues, sources and functions. Curr Opin Cell Biol, 24, 269-276.
98. Uhlhaas, P. J., Pipa, G., Lima, B., Melloni, L., Neuenschwander, S., Nikolic, D., et al. (2009). Neural synchrony in cortical networks: History, concept and current status. Front Integr Neurosci, 3, 17.
99. Uhlhaas, P. J., & Singer, W. (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci, 11, 100-113.
100. Wang, L., Lockstone, H. E., Guest, P. C., Levin, Y., Palotas, A., Pietsch, S., et al. (2010). Expression profi ling of fi broblasts identifi es cell cycle abnormalities in schizophrenia. J Proteome Res, 9, 521-527.
101. Wang, X. J. (2010). Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev, 90, 1195-1268.
102. Wang, Y., Chan, S. L., Miele, L., Yao, P. J., Mackes, J., Ingram, D. K., et al. (2004). Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci U S A, 101, 9458-9462. (Pubitemid 38812896)
103. Woo, T. U. W., Miller, J. L., & Lewis, D. A. (1997). Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry, 154, 1013-1015. (Pubitemid 27274547)
104. Woo, T. U. W., Spencer, K., & McCarley, R. W. (2010). Gamma oscillation defi cits and the onset and early progression of schizophrenia. Harv Rev Psychiatry, 18, 173-189.
105. Woo, T. U. W., Whitehead, R. E., Melchitzky, D. S., & Lewis, D. A. (1998). A subclass of prefrontal gammaaminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A, 95, 5341-5346. (Pubitemid 28208599)
106. Yang, X., Klein, R., Tian, X., Cheng, H. T., Kopan, R., & Shen, J. (2004). Notch activation induces apoptosis in neural progenitor cells through a p53-dependent pathway. Dev Biol, 269, 81-94. (Pubitemid 38471825)